Laboratory surveillance for wild and vaccine-derived polioviruses, January 2003-June 2004

Morbidity and Mortality Weekly Report

Volumn 53, Issue 42, 2004, Pages 990-993

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; CLASSIFICATION; DIAGNOSIS, MEASUREMENT AND ANALYSIS; GENOTYPE; HEALTH; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; POLIOMYELITIS; POLIOMYELITIS VIRUS; SEROTYPING; VIROLOGY;

GENOTYPE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; POPULATION SURVEILLANCE; SEROTYPING; WORLD HEALTH;

EID: 6944239065     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. CDC. Laboratory surveillance for wild poliovirus and vaccine-derived poliovirus, 2000-2001. MMWR 2002;51:369-71.
2. CDC. Developing and expanding contributions of the global laboratory network for poliomyelitis eradication, 1997-1999. MMWR 2000;49:156-60.
3. CDC. Status of the global laboratory network for poliomyelitis eradication, 1994-1996. MMWR 1997;46:692-4.
4. CDC. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2002-June 2003. MMWR 2003;52:913-6.
5. CDC. Apparent global interruption of wild poliovirus type 2 transmission. MMWR 2001;50:222-4.
6. Yang C-F, Naguib T, Yang S-J, et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 2003;77:8366-77.
7. Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002;296:356-9.
8. WHO. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus, Philippines, 2001. Wkly Epidemiol Rec 2001;76:319-20.
9. Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, et al. Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 2003;9:885-7.
10. Blomqvist Savollaine C, Laine P, Hirttio P, et al. Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol 2004;78:4876-83.